A Double-Blind, Randomized Controlled Trial of Hydroxychloroquine for Cognitive Dysfunction and Inflammatory Biomarkers in Systemic Lupus Erythematosus Patients in Indonesia

A Double-Blind, Randomized Controlled Trial of Hydroxychloroquine for Cognitive Dysfunction and Inflammatory Biomarkers in Systemic Lupus Erythematosus Patients in Indonesia

BACKGROUND: Systemic lupus erythematosus (SLE) is an autoimmune condition characterized by persistent, chronic inflammation that damages organ tissue. One of the symptoms that is often found in SLE is cognitive dysfunction. Hydroxychloroquine is recommended for the treatment of all levels of SLE. Th...

書誌詳細
主要な著者:	Bantar Suntoko, Suharyo Hadisaputro, Handono Kalim, Suyanto Hadi, Ika Vemilia Warlisti
フォーマット:	論文
言語:	English
出版事項:	Secretariat of The Indonesian Biomedical Journal 2023-08-01
シリーズ:	Indonesian Biomedical Journal
オンライン･アクセス:	https://inabj.org/index.php/ibj/article/view/2504

類似資料

Relationship Between Disease Activity, Levels of IFN-a, IL-4, IL-6, and Anti-NMDA to Cognitive Dysfunction (MoCA-INA Score) in Systemic Lupus Erythematosus (SLE) Patients with Cognitive Dysfunction
著者:: Bantar Suntoko, 等
出版事項: (2023-07-01)

Diagnosis and Management of Cognitive Dysfunction In Systemic Lupus Erythematosus Patients
著者:: Perdana Aditya Rahman, 等
出版事項: (2022-05-01)

Hyperuricemia and Pro Inflammatory Cytokine (IL-1Î², IL-6, and TNF-Î±)
著者:: Suyanto Hadi, 等
出版事項: (2018-02-01)

Advancements on the impact of hydroxychloroquine in systemic lupus erythematosus
著者:: Liu Peng-Cheng, 等
出版事項: (2024-05-01)

Periodontal Tissue Condition on Systemic Lupus Erythematosus Patients: A Clinical Study
著者:: Nanda Rachmad Putra Gofur, 等
出版事項: (2022-03-01)

Hydroxychloroquine-induced retinal toxicity in systemic lupus erythematosus
著者:: Kisha D Piggott, 等
出版事項: (2018-01-01)

Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge
著者:: Alina Dima, 等
出版事項: (2022-02-01)

Periodontal Comparison on Systemic Lupus Erythematosus Patients and Healthy Subjects: A Cross-Sectional Study
著者:: Nanda Rachmad Putra Gofur, 等
出版事項: (2021-11-01)

Periodontitis is associated with disease severity and anti-double stranded DNA antibody and interferon-gamma levels in patients with systemic lupus erythematosus
著者:: Nanda R.P. Gofur, MS, 等
出版事項: (2019-12-01)

Association between senescence of T cells and disease activity in patients with systemic lupus erythematosus
著者:: Handono Kalim, 等
出版事項: (2021-10-01)

New onset bullous lupus erythematosus in a systemic lupus erythematosus patient after initiation of hydroxychloroquin
著者:: Chanchal Gera, 等
出版事項: (2014-01-01)

Hydroxychloroquine in patients with systemic lupus erythematosus: how much is enough?
著者:: Guillermo Ruiz-Irastorza, 等
出版事項: (2025-02-01)

Hydroxychloroquine in systemic lupus erythematosus and psychosis. A case report
著者:: M. Martínez Grimal, 等
出版事項: (2024-04-01)

Outcomes of Systemic Lupus Erythematosus in Patients who Discontinue Hydroxychloroquine
著者:: Z. Aouhab, 等
出版事項: (2019-11-01)

Multichannel perimetric alterations in systemic lupus erythematosus treated with hydroxychloroquine
著者:: David P. Piñero, 等
出版事項: (2017-04-01)

Influence of hydroxychloroquine blood levels on adhesion molecules associated with endothelial dysfunction in patients with systemic lupus erythematosus
著者:: Michele Iudici, 等
出版事項: (2022-03-01)

Oral Hygiene and Dental Caries Status on Systemic Lupus Erythematosus Patients: A Cross-Sectional Study
著者:: Nanda Rachmad Putra Gofur, 等
出版事項: (2022-03-01)

Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus
著者:: Alberto Floris, 等
出版事項: (2018-01-01)

Hydroxychloroquine lowers the risk for Diabetes Mellitus in patients with Systemic Lupus Erythematosus
著者:: Dennis Levinson, 等
出版事項: (2022-10-01)

The phenotype of CD3–CD56bright and CD3–CD56dim natural killer cells in systemic lupus erythematosus patients and its relation to disease activity
著者:: Dwi Soelistyoningsih, 等
出版事項: (2022-08-01)

Assessment of SLEDAI score changes in systemic lupus erythematosus patients under low-dose interleukin-2 therapy: A meta-analysis
著者:: Dwi Soelistyoningsih, 等
出版事項: (2024-09-01)

S15.1 Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus
著者:: S Fasano, 等
出版事項: (2022-10-01)

The Correlation between Serum Concentration of Vitamin D with Vitamin D Receptor Expression and Disease Activity in Indonesian Patients with Systemic Lupus Erythematosus: Preliminary Study
著者:: Kusworini Handono, 等
出版事項: (2014-05-01)

Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence
著者:: Ronald F van Vollenhoven, 等
出版事項: (2021-04-01)

Successful treatment of cardiac tamponade with systemic lupus erythematosus using belimumab and hydroxychloroquine
著者:: Tomoo Kise, 等
出版事項: (2023-01-01)

An observational study to identify causative factors for not using hydroxychloroquine in systemic lupus erythematosus
著者:: Atsushi Manabe, 等
出版事項: (2024-04-01)

Effect of hydroxychloroquine blood concentration on the efficacy and ocular toxicity of systemic lupus erythematosus
著者:: Peng-Cheng Liu, 等
出版事項: (2024-04-01)

Evaluation of Hydroxychloroquine Blood Concentrations and Effects in Childhood-Onset Systemic Lupus Erythematosus
著者:: Noël Zahr, 等
出版事項: (2021-03-01)

Incidental retinal vascular occlusions on hydroxychloroquine screening in patients with systemic lupus erythematosus
著者:: Bajwa A, 等
出版事項: (2015-05-01)

Hydroxychloroquine-Induced Psoriasis-form Erythroderma in a Patient with Systemic Lupus Erythematosus
著者:: Wen-Ming Wang, 等
出版事項: (2018-01-01)

Extensive discoid lupus erythematosus in a HIV patient responding to hydroxychloroquine monotherapy
著者:: Pradeep Vittal Bhagwat, 等
出版事項: (2012-01-01)

Frequency and risk factors for hydroxychloroquine retinopathy among patients with systemic lupus erythematosus
著者:: Mohammed Salah Eldin Abdelbaky, 等
出版事項: (2021-06-01)

CS-31 Safety of hydroxychloroquine withdrawal in older adults with systemic lupus erythematosus
著者:: Anca Askanase, 等
出版事項: (2018-08-01)

Oculometric biomarkers of visuomotor deficits in clinically asymptomatic patients with systemic lupus erythematosus undergoing long-term hydroxychloroquine treatment
著者:: Andrew R. Berneshawi, 等
出版事項: (2024-07-01)

Hydroxychloroquine is associated with lower platelet activity and improved vascular health in systemic lupus erythematosus
著者:: Peter Izmirly, 等
出版事項: (2021-04-01)

Life Threatening Severe QTc Prolongation in Patient with Systemic Lupus Erythematosus due to Hydroxychloroquine
著者:: John P. O’Laughlin, 等
出版事項: (2016-01-01)

O9 Early pregnancy exposure to hydroxychloroquine and preterm delivery in systemic lupus erythematosus
著者:: Elisabet Svenungsson, 等
出版事項: (2024-03-01)

Nationwide patterns of hydroxychloroquine dosing and monitoring of retinal toxicity in patients with systemic lupus erythematosus
著者:: Jae-Eun Lee, 等
出版事項: (2023-05-01)

Hydroxychloroquine-induced hyperpigmentation in a 14-year-old female with systemic lupus erythematosus
著者:: Alexander KC Leung, 等
出版事項: (2020-07-01)

Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study
著者:: Ruth Fernandez-Ruiz, 等
出版事項: (2020-08-01)